Citadel Advisors
DNA icon

Citadel Advisors’s Ginkgo Bioworks DNA Stock Holding History

Citadel Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Sell
35,400
-101,600
-74% -$845K ﹤0.01% 11250
2025
Q4 		$1.14M Sell
137,000
-67,348
-33% -$725K ﹤0.01% 7104
2025
Q3 		$2.98M Sell
204,348
-240,556
-54% -$2.88M ﹤0.01% 5323
2025
Q2 		$5.01M Buy
444,904
+349,590
+367% +$2.71M ﹤0.01% 4113
2025
Q1 		$543K Buy
95,314
+35,552
+59% +$362K ﹤0.01% 8294
2024
Q4 		$587K Sell
59,762
-38
-0.1% -$326 ﹤0.01% 8204
2024
Q3 		$487K Buy
59,800
+52,242
+691% +$523K ﹤0.01% 8310
2024
Q2 		$101K Buy
7,558
+1,843
+32% +$55K ﹤0.01% 10909
2024
Q1 		$265K Sell
5,715
-1,665
-23% -$86.2K ﹤0.01% 9740
2023
Q4 		$499K Sell
7,380
-1,537
-17% -$94.1K ﹤0.01% 8116
2023
Q3 		$646K Sell
8,917
-1,429
-14% -$114K ﹤0.01% 7510
2023
Q2 		$770K Buy
10,346
+832
+9% +$49.2K ﹤0.01% 7007
2023
Q1 		$506K Sell
9,514
-14,696
-61% -$931K ﹤0.01% 8282
2022
Q4 		$1.64M Buy
24,210
+3,937
+19% +$362K ﹤0.01% 5858
2022
Q3 		$2.53M Buy
20,273
+8,463
+72% +$1.01M ﹤0.01% 5138
2022
Q2 		$1.12M Sell
11,810
-1,833
-13% -$224K ﹤0.01% 6759
2022
Q1 		$2.2M Buy
13,643
+770
+6% +$150K ﹤0.01% 5884
2021
Q4 		$4.28M Sell
12,873
-3,222
-20% -$1.53M ﹤0.01% 4613
2021
Q3 		$7.46M Buy
+16,095
New +$7.84M ﹤0.01% 3577

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's DNA Position: Q3 2025 in Review

Citadel Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 10,114 shares — an estimated $121K sold.

Citadel Advisors first reported a position in DNA in Q3 2021 and held it in 13 quarters. The position peaked at $12M in Q3 2021. 173 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • Citadel Advisors reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 10,114 Ginkgo Bioworks shares in Q3 2025, an estimated $121K.
  • Citadel Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 13 quarters.
  • Citadel Advisors's Ginkgo Bioworks position peaked at $12M in Q3 2021.
  • 173 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.